13F HOLDINGS REPORT
StepStone Group LP
Quarter ended Q1 2023 · Filed February 10, 2023 · Accession 0000950123-23-001451
Total Value
$766.5M
Positions
24
Other Managers
0
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Dun & Bradstreet Holdings, Inc. | 26484T106 | 22,042,226 | $270.2M | 35.26% |
| 2 | User Testing | 91734E101 | 22,680,906 | $170.3M | 22.22% |
| 3 | Walkme Ltd. | M97628107 | 10,366,855 | $115.9M | 15.12% |
| 4 | Rocket Lab USA Inc | RKLB | 12,273,414 | $46.3M | 6.04% |
| 5 | Bright Health Group Inc. | 10920V107 | 42,022,244 | $27.3M | 3.56% |
| 6 | UiPath Inc | PATH | 1,786,527 | $22.7M | 2.96% |
| 7 | Imago Biosciences Inc | 45250K107 | 522,987 | $18.8M | 2.45% |
| 8 | MoneyLion | 60938K106 | 25,384,780 | $17.3M | 2.26% |
| 9 | Roblox Corporation | RBLX | 469,052 | $13.3M | 1.74% |
| 10 | HilleVax Inc | 43157M102 | 676,567 | $11.3M | 1.48% |
| 11 | Rover Group Inc | 77936F903 | 2,849,340 | $10.5M | 1.36% |
| 12 | Entrada Therapeutics Inc | TRDA | 761,277 | $10.3M | 1.34% |
| 13 | NGM Biopharmaceuticals Inc | 62921N105 | 1,573,357 | $7.9M | 1.03% |
| 14 | Doma Holdings Inc(f/k/a States Title Holding Inc) | 25703A104 | 14,879,484 | $6.7M | 0.87% |
| 15 | Oblong Inc | 674434105 | 3,692,661 | $6.6M | 0.87% |
| 16 | Phathom Pharmaceuticals Inc | PHAT | 422,085 | $4.7M | 0.62% |
| 17 | Vacasa Inc. | 91854V107 | 3,013,815 | $3.8M | 0.50% |
| 18 | Tenaya Therepeutics Inc | TNYA | 462,163 | $928,948 | 0.12% |
| 19 | Grove Collaborative Holdings Inc | GROVW | 1,886,726 | $754,690 | 0.10% |
| 20 | JFrog Ltd | FROG | 23,987 | $511,643 | 0.07% |
| 21 | Amplitude Inc | AMPL | 4,972 | $60,062 | 0.01% |
| 22 | Sweetgreen Inc | SG | 6,379 | $54,668 | 0.01% |
| 23 | Confluent Inc | 20717M103 | 2,447 | $54,421 | 0.01% |
| 24 | Amyris Inc | 03236M200 | 2,816 | $4,308 | 0.00% |